Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

A comparison of rt-PA thrombolysis guidelines between China and the USA: are changes needed?

Xu J, Zhang Y, Wei H, Xu Y, Wang M, Cai Z, Li X.

Neurol Res. 2015 Jan;37(1):57-63. doi: 10.1179/1743132814Y.0000000415. Epub 2014 Jul 1. Review.

PMID:
24981554
2.

Consensus statement on the use of intravenous recombinant tissue plasminogen activator to treat acute ischemic stroke by the Chinese Stroke Therapy Expert Panel.

Xu AD, Wang YJ, Wang DZ; Chinese Stroke Therapy Expert Panel for Intravenous Recombinant Tissue Plasminogen Activator.

CNS Neurosci Ther. 2013 Aug;19(8):543-8. doi: 10.1111/cns.12126. Epub 2013 May 27.

PMID:
23710819
3.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
4.

Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.

Asaithambi G, Chaudhry SA, Hassan AE, Rodriguez GJ, Suri MF, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):e42-5. doi: 10.1016/j.jstrokecerebrovasdis.2012.03.018. Epub 2012 May 8.

PMID:
22572162
5.

Pennsylvania comprehensive stroke center collaborative: Statement on the recently updated IV rt-PA prescriber information for acute ischemic stroke.

Daou B, Deprince M, D'Ambrosio R, Tjoumakaris S, Rosenwasser RH, Ackerman DJ, Bell R, Tzeng DL, Ghobrial M, Fernandez A, Shah Q, Gzesh DJ, Murphy D, Castaldo JE, Mathiesen C, Pineda MC, Jabbour P.

Clin Neurol Neurosurg. 2015 Dec;139:264-8. doi: 10.1016/j.clineuro.2015.10.010. Epub 2015 Oct 21.

PMID:
26539671
6.

The use of intravenous recombinant tissue plasminogen activator in acute ischemic stroke.

Kahn JH, Viereck J, Kase C, Jeerakathil T, Romero R, Mehta SD, Kociol R, Babikian V.

J Emerg Med. 2005 Oct;29(3):273-7.

PMID:
16183445
7.

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial.

Zinkstok SM, Vermeulen M, Stam J, de Haan RJ, Roos YB; ARTIS study group.

Trials. 2010 May 12;11:51. doi: 10.1186/1745-6215-11-51.

8.

Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke.

Cappellari M, Moretto G, Micheletti N, Donato F, Tomelleri G, Gulli G, Carletti M, Squintani GM, Zanoni T, Ottaviani S, Romito S, Tommasi G, Musso AM, Deotto L, Gambina G, Zimatore DS, Bovi P.

J Thromb Thrombolysis. 2014 May;37(4):549-56. doi: 10.1007/s11239-013-0980-2.

PMID:
23943338
9.

Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.

Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE; American Heart Association Stroke Council and Council on Epidemiology and Prevention.

Stroke. 2016 Feb;47(2):581-641. doi: 10.1161/STR.0000000000000086. Epub 2015 Dec 22. Review. Erratum in: Stroke. 2016 Nov;47(11):e262.

10.

Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?

Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.

J Stroke Cerebrovasc Dis. 2013 May;22(4):545-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.022. Epub 2013 Feb 28.

PMID:
23453555
11.

Thrombolysis for acute ischaemic stroke.

Wardlaw JM, Zoppo G, Yamaguchi T, Berge E.

Cochrane Database Syst Rev. 2003;(3):CD000213. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD000213.

PMID:
12917889
12.

Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.

Williams JM, Navin TJ, Jude MR, Levi CR.

Aust J Rural Health. 2013 Aug;21(4):203-7. doi: 10.1111/ajr.12038.

PMID:
24033520
13.

Changing contraindications for t-PA in acute stroke: review of 20 years since NINDS.

Parker S, Ali Y.

Curr Cardiol Rep. 2015 Oct;17(10):81. doi: 10.1007/s11886-015-0633-5. Review.

PMID:
26277361
14.

[Intravenous thrombolysis in ischemic stroke: Therapeutic perspectives].

Paris C, Derex L.

Rev Neurol (Paris). 2015 Dec;171(12):866-75. doi: 10.1016/j.neurol.2015.09.002. Epub 2015 Nov 10. Review. French.

PMID:
26563662
15.

[Prospects of thrombolytic therapy for acute ischemic stroke].

Nakashima T, Minematsu K.

Brain Nerve. 2009 Sep;61(9):1003-12. Review. Japanese.

PMID:
19803399
16.

Alteplase in acute ischemic stroke: putting the guidelines into practice.

Nagaraja N, Adams HP Jr.

CNS Drugs. 2014 Nov;28(11):1035-45. doi: 10.1007/s40263-014-0204-0. Review.

PMID:
25326784
18.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
19.

Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.

Al-Khaled M, Matthis C, Eggers J.

J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11.

PMID:
22578915
20.

Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.

Seet RC, Rabinstein AA.

Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Review.

Supplemental Content

Support Center